Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Corvus Pharma
CRVS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$6.01
0.91
17.91%
Last update: 3:32 PM
15 minutes delayed
Why is it moving?
Corvus Pharmaceuticals shares are trading higher after Ladenburg maintained a Buy rating on the stock and raised its price target from $12 to $21.
Get Report
Comment
Corvus Pharma (CRVS) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Corvus Pharma (NASDAQ:CRVS) Stock
Corvus Pharma Stock (NASDAQ: CRVS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, September 16, 2024
Corvus Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Ladenburg Thalmann Maintains Buy on Corvus Ph...
Benzinga Newsdesk
Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Tuesday, September 10, 2024
Corvus Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Corvus Pharmaceuticals Initiates Registration...
Benzinga Newsdesk
Friday, August 09, 2024
Corvus Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Wednesday, August 07, 2024
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, August 06, 2024
Corvus Pharma Q2 EPS $(0.07) Beats $(0.12) Es...
Benzinga Newsdesk
Thursday, August 01, 2024
Corvus Pharmaceuticals Announces FDA Fast Tra...
Benzinga Newsdesk
Thursday, July 25, 2024
Corvus Pharmaceuticals Announces Publication ...
Benzinga Newsdesk
Tuesday, May 07, 2024
Corvus Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Corvus Ph...
Benzinga Newsdesk
Monday, May 06, 2024
Corvus Pharma Expects FY24 Net Cash Used In O...
Benzinga Newsdesk
Corvus Pharma Q1 2024 GAAP EPS $(0.12), Inlin...
Benzinga Newsdesk
Thursday, May 02, 2024
Corvus Pharmaceuticals Announces Pricing Of $...
Benzinga Newsdesk
Tuesday, April 09, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Corvus Pharmaceuticals Announces Initiation O...
Benzinga Newsdesk
Monday, April 01, 2024
Cantor Fitzgerald Reiterates Overweight on Co...
Benzinga Newsdesk
Wednesday, March 27, 2024
Mizuho Maintains Neutral on Corvus Pharma, Ma...
Benzinga Newsdesk
Wednesday, March 20, 2024
Oppenheimer Maintains Outperform on Corvus Ph...
Benzinga Newsdesk
Tuesday, March 19, 2024
Corvus Pharma Q4 EPS $(0.14) Misses $(0.12) Estimate
Happy Mohamed
Earnings Scheduled For March 19, 2024
Benzinga Insights
Monday, March 18, 2024
Earnings Outlook For Corvus Pharma
Benzinga Insights
Monday, February 12, 2024
Corvus Pharmaceuticals Presents Soquelitinib ...
Benzinga Newsdesk
Friday, February 09, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, February 08, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Corvus Pharmaceuticals Says FDA Granted Orpha...
Benzinga Newsdesk
Monday, December 11, 2023
Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Saturday, Corvus Pharmaceuticals Announced Ne...
Benzinga Newsdesk
Tuesday, November 07, 2023
Corvus Pharma Q3 EPS $(0.12), Inline
Benzinga Newsdesk
Earnings Scheduled For November 7, 2023
Benzinga Insights
Monday, November 06, 2023
Preview: Corvus Pharma's Earnings
Benzinga Insights
Thursday, November 02, 2023
Corvus Pharmaceuticals To Present New Interim...
Benzinga Newsdesk
Reported Earlier, Corvus Pharmaceuticals Publ...
Benzinga Newsdesk
Thursday, September 07, 2023
Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Cantor Fitzgerald Reiterates Overweight on Co...
Benzinga Newsdesk
Wednesday, September 06, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Corvus Pharmaceuticals Confirms Planned Initiation Of Soquelitinib Phase 3 Registrational Clinical Trial In Peripheral T Cell Lymphoma Following Meeting With FDA
Happy Mohamed
Friday, August 18, 2023
Corvus Pharmaceuticals Eyes Expansion Of Blood Cancer Therapy but Resource Limitations Pose Challenge: Oppenheimer
Vandana Singh
Tuesday, August 08, 2023
Corvus Pharma Q2 EPS $(0.14), Inline
Benzinga Newsdesk
Earnings Scheduled For August 8, 2023
Benzinga Insights
Monday, July 10, 2023
Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Thursday, July 06, 2023
Corvus Pharmaceuticals Announces Publication Of Preclinical Data Demonstrating Potential Novel Approach To Immunotherapy Based On Inhibition Of ITK With Soquelitinib
Happy Mohamed
Thursday, June 29, 2023
Corvus Pharmaceuticals Announced New Preclini...
Benzinga Newsdesk
Friday, June 16, 2023
The Latest Analyst Ratings for Corvus Pharma
Benzinga Insights
Mizuho Reiterates Neutral on Corvus Pharma, M...
Benzinga Newsdesk
Thursday, June 15, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Corvus Pharmaceuticals Says Updated Data From...
Benzinga Newsdesk
Tuesday, May 30, 2023
Ladenburg Thalmann Maintains Buy on Corvus Ph...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
